Randomized Trial of Avelumab-cetuximab-radiotherapy Versus SOCs in LA SCCHN (REACH)
Clinical trial NCT02999087 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02999087
- Sponsor
- Groupe Oncologie Radiotherapie Tete et Cou
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-14
- Primary completion
- 2027-12-01
- Enrollment
- 707
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.